Exp Neurobiol.  2015 Jun;24(2):95-102. 10.5607/en.2015.24.2.95.

Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases

• Woo JH
• Lee JH
• Kim H
• Park SJ
• Joe EH
• Jou I

• KMID: 2165543
• DOI: http://doi.org/10.5607/en.2015.24.2.95

Abstract

The term 'inflammation' was first introduced by Celsus almost 2000 years ago. Biological and medical researchers have shown increasing interest in inflammation over the past few decades, in part due to the emerging burden of chronic and degenerative diseases resulting from the increased longevity that has arisen thanks to modern medicine. Inflammation is believed to play critical roles in the pathogenesis of degenerative brain diseases, including Alzheimer's disease and Parkinson's disease. Accordingly, researchers have sought to combat such diseases by controlling inflammatory responses. In this review, we describe the endogenous inflammatory stimulators and signaling pathways in the brain. In particular, our group has focused on the JAK-STAT pathway, identifying anti-inflammatory targets and testing the effects of various anti-inflammatory drugs. This work has shown that the JAK-STAT pathway and its downstream are negatively regulated by phosphatases (SHP2 and MKP-1), inhibitory proteins (SOCS1 and SOCS3) and a nuclear receptor (LXR). These negative regulators are controlled at various levels (e.g. transcriptional, post-transcriptional and post-translational). Future study of these proteins could facilitate the manipulation of the inflammatory response, which plays ubiquitous, diverse and ambivalent roles under physiological and pathological conditions.

Keyword

inflammation; JAK-STAT; nuclear receptor; liver X receptor; post-transcriptional regulation; MKP-1

MeSH Terms

Alzheimer Disease
Brain
Brain Diseases
History, Modern 1601-
Inflammation
Longevity
Neurons*
Parkinson Disease
Phosphoric Monoester Hydrolases
Phosphoric Monoester Hydrolases